Molecular and Cellular Biochemistry

, Volume 220, Issue 1–2, pp 1–13 | Cite as

The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II)

  • Yuanyue Zhou
  • William Gross
  • Suk-Hyun Hong
  • Martin L. Privalsky

Abstract

The Silencing-Mediator for Retinoid/Thyroid hormone receptors (SMRT) interacts with, and mediates transcriptional repression by, a variety of eukaryotic transcription factors, including the nuclear hormone receptors. The ability of SMRT to function as a transcriptional ‘corepressor’ is regulated by a variety of signal transduction pathways. We report here that SMRT is a phosphoprotein in vivo, and is also phosphorylated in vitro by unfractionated cell extracts. A major site of phosphorylation of SMRT is a protein kinase CK2 motif centered on serine 1492, and located within a C-terminal SMRT domain that mediates interaction of the corepressor with the nuclear hormone receptors. Phosphorylation of SMRT by CK2 stabilizes the ability of the SMRT protein to interact with nuclear hormone receptors. Our results indicate that SMRT is a member of an expanding family of transcriptional regulators that are modified, and potentially regulated, in response to proteinkinase CK2.

corepressor nuclear hormone receptors protein kinase CK2 casein kinase 2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, Kushner PJ, West BL, Nilsson S, Scanlan TS, Fletterick RJ, Baxter JD: Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol 25(suppl): S2–S11, 1998Google Scholar
  2. 2.
    Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: The second decade. Cell 83: 835–839, 1995Google Scholar
  3. 3.
    Lazar MA: Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 14: 184–193, 1993Google Scholar
  4. 4.
    Meier CA: Regulation of gene expression by nuclear hormone receptors. J Recept Signal Transduct Res 17: 319–335, 1997Google Scholar
  5. 5.
    Tsai MJ, O'Malley BW: Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu Rev Biochem 63: 451–486, 1994Google Scholar
  6. 6.
    Damm K, Thompson CC, Evans RM: Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339: 593–597, 1989Google Scholar
  7. 7.
    Sap J, Muñoz A, Schmitt J, Stunnenberg H, Vennström B: Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 340: 242–244, 1989Google Scholar
  8. 8.
    Sjoberg M, Vennstrom B: Ligand-dependent and-independent transactivation by thyroid hormone receptor beta-2 is determined by the structure of the hormone response element. Mol Cell Biol 15: 4718–4726, 1995Google Scholar
  9. 9.
    Schulman IG, Juguilon H, Evans RM: Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states. Mol Cell Biol 16: 3807–3813, 1996Google Scholar
  10. 10.
    Collingwood TN, Urnov FD, Wolffe AP: Nuclear receptors: Coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 23: 255–275, 1999Google Scholar
  11. 11.
    Chen JD, Li H: Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Crit Rev Eukaryot Gene Expr 8: 169–190, 1998Google Scholar
  12. 12.
    Hassig CA, Schreiber SL: Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1: 300–308, 1997Google Scholar
  13. 13.
    Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L: Nuclear receptor coactivators and corepressors. Mol Endocrinol 10: 1167–1177, 1996Google Scholar
  14. 14.
    Torchia J, Glass C, Rosenfeld MG: Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10: 373–383, 1998Google Scholar
  15. 15.
    Chen JD, Evans RM: A transcriptional co-repressor that interacts with nuclear hormone receptors (see comments). Nature 377: 454–457, 1995Google Scholar
  16. 16.
    Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor (see comments). Nature 377: 397–404, 1995Google Scholar
  17. 17.
    Sande S, Privalsky ML: Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10: 813–825, 1996Google Scholar
  18. 18.
    Seol W, Mahon MJ, Lee YK, Moore DD: Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol Endocrinol 10: 1646–1655, 1996Google Scholar
  19. 19.
    Zamir I, Harding HP, Atkins GB, Hörlein A, Glass CK, Rosenfeld MG, Lazar MA: A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16: 5458–5465, 1996Google Scholar
  20. 20.
    Ito M, Yuan CX, Malik S, Gu W, Fondell JD, Yamamura S, Fu ZY, Zhang X, Qin J, Roeder RG: Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell 3: 361–370, 1999Google Scholar
  21. 21.
    Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Näär AM, Erdjument-Bromage H, Tempst P, Freedman LP: Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398: 824–828, 1999Google Scholar
  22. 22.
    Xu L, Glass CK, Rosenfeld MG: Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9: 140–147, 1999Google Scholar
  23. 23.
    Chen JD: Steroid/nuclear receptor coactivators. Vit Horm 58: 391–448, 2000Google Scholar
  24. 24.
    Ayer DE: Histone deacetylases: Transcriptional repression with SINers and NuRDs. Trends Cell Biol 9: 193–198, 1999Google Scholar
  25. 25.
    Kuo MH, Allis CD: Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20: 615–626, 1998Google Scholar
  26. 26.
    Lin RJ, Kao HY, Ordentlich P, Evans RM: The transcriptional basis of steroid physiology. Cold Spring Harb Symp Quant Biol 63: 577–585, 1998Google Scholar
  27. 27.
    Muscat GE, Burke LJ, Downes M: The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucleic Acids Res 26: 2899–2907, 1998Google Scholar
  28. 28.
    Struhl K: Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599–606, 1998Google Scholar
  29. 29.
    Suka N, Carmen AA, Rundlett SE, Grunstein M: The regulation of gene activity by histones and the histone deacetylase RPD3. Cold Spring Harb Symp Quant Biol 63: 391–399, 1998Google Scholar
  30. 30.
    Wong CW, Privalsky ML: Transcriptional repression by the SMRTmSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol 18: 5500–5510, 1998Google Scholar
  31. 31.
    Wu C: Chromatin remodeling and the control of gene expression. J Biol Chem 272: 28171–28174, 1997Google Scholar
  32. 32.
    Hu X, Lazar MA: The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 93–96, 1999Google Scholar
  33. 33.
    Lin BC, Hong SH, Krig S, Yoh SM, Privalsky ML: A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol 17: 6131–6138, 1997Google Scholar
  34. 34.
    Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JW: Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13: 3209–3216, 1999Google Scholar
  35. 35.
    Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG: Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13: 3198–3208, 1999Google Scholar
  36. 36.
    Hong SH, Wong CW, Privalsky ML: Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. Mol Endocrinol 12: 1161–1171, 1998Google Scholar
  37. 37.
    Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW: Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 95: 2920–2925, 1998Google Scholar
  38. 38.
    Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP: The nuclear corepressors NCoR and SMRT are key regulators of both ligand-and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 18: 1369–1378, 1998Google Scholar
  39. 39.
    Hong S-K, Privalsky ML: SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. (in press)Google Scholar
  40. 40.
    Hong SH, David G, Wong CW, Dejean A, Privalsky ML: SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94: 9028–9033, 1997Google Scholar
  41. 41.
    Ausubel FM: Current protocols in molecular biology, Wiley-Interscience, New York, 2000Google Scholar
  42. 42.
    Bolla DM, Edelstein SJ: In: Protein Methods. Wiley-Liss, New York, 1991Google Scholar
  43. 43.
    Pinna LA, Meggio F: Protein kinase CK2 ('casein kinase-2') and its implication in cell division and proliferation. Prog Cell Cycle Res 3: 77–97, 1997Google Scholar
  44. 44.
    Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N et al.: Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol Cell Biol 15: 5682–5687, 1995Google Scholar
  45. 45.
    Lin R, Beauparlant P, Makris C, Meloche S, Hiscott J: Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol Cell Biol 16: 1401–1409, 1996Google Scholar
  46. 46.
    Wisniewski JR, Szewczuk Z, Petry I, Schwanbeck R, Renner U: Constitutive phosphorylation of the acidic tails of the high mobility group 1 proteins by casein kinase II alters their conformation, stability, and DNA binding specificity. J Biol Chem 274: 20116–20122, 1999Google Scholar
  47. 47.
    Ray-Gallet D, Moreau-Gachelin F: Phosphorylation of the Spi-B transcription factor reduces its intrinsic stability. FEBS Lett 464: 164–168, 1999Google Scholar
  48. 48.
    Jans DA, Jans P: Negative charge at the casein kinase II site flanking the nuclear localization signal of the Sv40 large T-antigen is mechanistically important for enhanced nuclear import. Oncogene 9: 2961–2968, 1994Google Scholar
  49. 49.
    Oelgeschlager M, Krieg J, Luscherfirzlaff JM, Luscher B: Casein kinase II phosphorylation site mutations in C-myb affect DNA binding and transcriptional cooperativity with Nf-M. Mol Cell Biol 15: 5966–5974, 1995Google Scholar
  50. 50.
    Porter CM, Havens MA, Clipstone NA: Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J Biol Chem 275: 3543–3551, 2000Google Scholar
  51. 51.
    Alconada A, Bauer U, Hoflack B: A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network. EMBO J 15: 6096–6110, 1996Google Scholar
  52. 52.
    Söderström M, Vo A, Heinzel T, Lavinsky RM, Yang WM, Seto E, Peterson DA, Rosenfeld MG, Glass CK: Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol Endocrinol 11: 682–692, 1997Google Scholar
  53. 53.
    Blok LJ, de Ruiter PE, Brinkmann AO: Androgen receptor phosphorylation. Endocr Res 22: 197–219, 1996Google Scholar
  54. 54.
    Bodwell JE, Webster JC, Jewell CM, Cidlowski JA, Hu JM, Munck A: Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol 65: 91–99, 1998Google Scholar
  55. 55.
    Katzenellenbogen BS: Estrogen receptors: Bioactivities and interactions with cell signaling pathways. Biol Reprod 54: 287–293, 1996Google Scholar
  56. 56.
    Smith CL: Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 58: 627–632, 1998Google Scholar
  57. 57.
    Weigel NL: Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319: 657–667, 1996Google Scholar
  58. 58.
    Rowan BG, Weigel NL, O'Malley BW: Phosphorylation of steroid receptor coactivator-1 - identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275: 4475–4483, 2000Google Scholar
  59. 59.
    Ordentlich P, Downes M, Xie W, Genin A, Spinner NB, Evans RM: Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci USA 96: 2639–2644, 1999Google Scholar
  60. 60.
    Park EJ, Schroen DJ, Yang M, Li H, Li L, Chen JD: SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci USA 96: 3519–3524, 1999Google Scholar
  61. 61.
    Wong CW, Privalsky ML: Transcriptional silencing is defined by isoform-and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol 18: 5724–5733, 1998Google Scholar
  62. 62.
    Zamir I, Zhang J, Lazar MA: Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev 11: 835–846, 1997Google Scholar
  63. 63.
    Cohen RN, Wondisford FE, Hollenberg AN: Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol Endocrinol 12: 1567–1581, 1998Google Scholar
  64. 64.
    Baniahmad A, Dressel U, Renkawitz R: Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR. Mol Endocrinol 12: 504–512, 1998Google Scholar
  65. 65.
    Chen JD, Umesono K, Evans RM: SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93: 7567–7571, 1996Google Scholar
  66. 66.
    Downes M, Burke LJ, Bailey PJ, Muscat GE: Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: Physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res 24: 4379–4386, 1996Google Scholar
  67. 67.
    Li H, Leo C, Schroen DJ, Chen JD: Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol Endocrinol 11: 2025–2037, 1997Google Scholar
  68. 68.
    Allende JE, Allende CC: Protein kinases. 4. Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation. FASEB J 9: 313–323, 1995Google Scholar
  69. 69.
    Ghavidel A, Hockman DJ, Schultz MC: A review of progress towards elucidating the role of protein kinase CK2 in polymerase III transcription: Regulation of the TATA binding protein. Mol Cell Biochem 191: 143–148, 1999Google Scholar
  70. 70.
    Guerra B, Issinger OG: Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20: 391–408, 1999Google Scholar
  71. 71.
    Guerra B, Boldyreff B, Sarno S, Cesaro L, Issinger OG, Pinna LA: CK2: A protein kinase in need of control. Pharmacol Ther 82: 303–313, 1999Google Scholar
  72. 72.
    Pinna LA: Protein kinase CK2. Int J Biochem Cell Biol 29: 551–554, 1997Google Scholar
  73. 73.
    Rihs HP, Jans DA, Fan H, Peters R: The rate of nuclear cytoplasmic protein transport is determined by the casein kinase-II site flanking the nuclear localization sequence of the Sv40 T-antigen. Embo J 10: 633–639, 1991Google Scholar
  74. 74.
    Bousset K, Oelgeschlager MHH, Henriksson M, Schreek S, Burkhardt H, Litchfield DW, Luscherfirzlaff JM, Luscher B: Regulation of transcription factors C-myc, max, and C-myb by casein kinase II. Cell Mol Biol Res 40: 501–511, 1994Google Scholar
  75. 75.
    Lin AN, Frost J, Deng TL, Smeal T, Alalawi N, Kikkawa U, Hunter T, Brenner D, Karin M: Casein kinase-II is a negative regulator of c-Jun DNA binding and Ap-1 activity. Cell 70: 777–789, 1992Google Scholar
  76. 76.
    Rethinaswamy A, Birnbaum MJ, Glover CVC: Temperature-sensitive mutations of the CKA1 gene reveal a role for casein kinase II in maintenance of cell polarity in Saccharomyces cerevisae. J Biol Chem 273: 5869–5877, 1998Google Scholar
  77. 77.
    Roussou I, Draetta G: The Schizosaccharomyces-Pombe casein kinase-II alpha-subunit and beta-subunit - evolutionary conservation and positive role of the beta-subunit. Mol Cell Biol 14: 576–586, 1994Google Scholar
  78. 78.
    Ospina B, Nunez A, Fernandezrenart M: Purification of a soluble casein kinase-II from dictyostelium-discoideum lacking the beta-subunit - regulation during proliferation and differentiation. Mol Cell Biochem 118: 49–60, 1992Google Scholar
  79. 79.
    Kikkawa U, Mann SKO, Firtel RA, Hunter T: Molecular cloning of casein kinase-II alpha-subunit from dictyostelium-discoideum and its expression in the life cycle. Mol Cell Biol 12: 5711–5723, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Yuanyue Zhou
    • 1
  • William Gross
    • 1
  • Suk-Hyun Hong
    • 1
  • Martin L. Privalsky
    • 1
  1. 1.Section of Microbiology, Division of Biological SciencesUniversity of California at DavisDavisUSA

Personalised recommendations